| 20.27 -0.02 (-0.1%) | 08-07 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 24.51 | 1-year : | 28.63 |
| Resists | First : | 20.98 | Second : | 24.51 |
| Pivot price | 19.87 |
|||
| Supports | First : | 19.58 |
Second : | 18.71 |
| MAs | MA(5) : | 20.19 |
MA(20) : | 19.79 |
| MA(100) : | 17.32 |
MA(250) : | 19.75 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 66.2 |
D(3) : | 61.2 |
| RSI | RSI(14): 58.2 |
|||
| 52-week | High : | 27.89 | Low : | 12.84 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ STVN ] has closed below upper band by 24.8%. Bollinger Bands are 29.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 20.33 - 20.41 | 20.41 - 20.49 |
| Low: | 19.63 - 19.72 | 19.72 - 19.8 |
| Close: | 20.14 - 20.29 | 20.29 - 20.42 |
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
Fri, 07 Aug 2026
Stevanato Group S.p.A. SEC Filing (Aug 7, 2026) - Stock Titan
Thu, 06 Aug 2026
Stevanato Group (NYSE: STVN) targets 26.8% 2026 EBITDA margin - Stock Titan
Wed, 05 Aug 2026
Stevanato Group S.p.A. Stock 12‑Month Price Target Raised to $25.1, Implies 28% Upside - TradingView
Wed, 05 Aug 2026
335,493 Shares in Stevanato Group S.p.A. $STVN Purchased by Confluence Investment Management LLC - MarketBeat
Wed, 05 Aug 2026
Lazard Asset Management LLC Purchases New Position in Stevanato Group S.p.A. $STVN - MarketBeat
Tue, 04 Aug 2026
Stevanato Group SpA (STVN) (Q2 2026) Earnings Call Highlights: Biologics Surge and Alina ... - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 50 (M) |
| Shares Float | 49 (M) |
| Held by Insiders | 1.6 (%) |
| Held by Institutions | 94 (%) |
| Shares Short | 966 (K) |
| Shares Short P.Month | 910 (K) |
| EPS | 0.57 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.4 |
| Profit Margin | 11.7 % |
| Operating Margin | 14.2 % |
| Return on Assets (ttm) | 5.2 % |
| Return on Equity (ttm) | 9.5 % |
| Qtrly Rev. Growth | 6.5 % |
| Gross Profit (p.s.) | 7.07 |
| Sales Per Share | 24.14 |
| EBITDA (p.s.) | 5.8 |
| Qtrly Earnings Growth | 2.9 % |
| Operating Cash Flow | 262 (M) |
| Levered Free Cash Flow | -57 (M) |
| PE Ratio | 35.05 |
| PEG Ratio | 3.5 |
| Price to Book value | 3.17 |
| Price to Sales | 0.84 |
| Price to Cash Flow | 3.86 |
| Dividend | 0.05 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|